CD45 is required for CD40-induced inhibition of DNA synthesis and regulation of c-Jun NH2-terminal kinase and p38 in BAL-17 B cells

被引:11
作者
Arimura, Y
Ogimoto, M
Mitomo, K
Katagiri, T
Yamamoto, K
Volarevic, S
Mizuno, K
Yakura, H
机构
[1] Tokyo Metropolitan Org Med Res, Dept Immunol & Signal Transduct, Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan
[2] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan
[3] Friedrich Miescher Inst, CH-4002 Basel, Switzerland
关键词
D O I
10.1074/jbc.M009242200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stimulation of B cell antigen receptor (BCR) may induce proliferation, differentiation, or apoptosis, depending upon the maturational stage of the cell and the presence or absence of signals transmitted via coreceptors. One such signal is delivered via CD40; for instance, ligation of CD40 rescues B cells from BCR-induced apoptosis. Here we show that, in contrast to WEHI-231 cells, CD40 ligation did not reverse BCR-induced growth inhibition in the BAL-17 mature B cell line and CD40 ligation itself inhibited proliferation. This inhibitory signaling was not observed in CD45-deficient cells. Further analyses demonstrate that transfection of dominant-negative form of SEK1 or treatment with SB203580 strongly reduced CD40-induced inhibition of BAL-17 proliferation, suggesting a requirement for c-Jun NH2-terminal kinase and p38 in CD40-induced inhibition of proliferation. Interestingly, CD40-initiated activation of c-Jun NH2-terminal kinase and p38 was enhanced and sustained in CD45-deficient cells, and these phenotypes were reversed by transfecting CD45 gene. However, CD40-mediated induction of cell surface molecules was not affected in CD45-deficient cells. Taken collectively, these results suggest that CD45 exerts a decisive effect on selective sets of CD40-mediated signaling pathways, dictating B cell fate.
引用
收藏
页码:8550 / 8556
页数:7
相关论文
共 48 条
  • [1] LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40
    BANCHEREAU, J
    DEPAOLI, P
    VALLE, A
    GARCIA, E
    ROUSSET, F
    [J]. SCIENCE, 1991, 251 (4989) : 70 - 72
  • [2] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [3] BARRETT TB, 1991, J IMMUNOL, V146, P1722
  • [4] Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases
    Berberich, I
    Shu, G
    Siebelt, F
    Woodgett, JR
    Kyriakis, JM
    Clark, EA
    [J]. EMBO JOURNAL, 1996, 15 (01) : 92 - 101
  • [5] BERBERICH I, 1994, J IMMUNOL, V153, P4357
  • [6] CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4(+)CD8(+) thymocytes, and in B cell maturation
    Byth, KF
    Conroy, LA
    Howlett, S
    Smith, AJH
    May, J
    Alexander, DR
    Holmes, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) : 1707 - 1718
  • [7] Clark LB, 1996, ADV IMMUNOL, V63, P43
  • [8] Craxton A, 1998, J IMMUNOL, V161, P3225
  • [9] Eliopoulos AG, 1996, ONCOGENE, V13, P2243
  • [10] CD40 SIGNALING PATHWAY - ANTI-CD40 MONOCLONAL-ANTIBODY INDUCES RAPID DEPHOSPHORYLATION AND PHOSPHORYLATION OF TYROSINE-PHOSPHORYLATED PROTEINS INCLUDING PROTEIN-TYROSINE KINASE LYN, FYN, AND SYK AND THE APPEARANCE OF A 28-KD TYROSINE-PHOSPHORYLATED PROTEIN
    FARIS, M
    GASKIN, F
    PARSONS, JT
    FU, SM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) : 1923 - 1931